Ansh Labs
- Company typePrivate
- Founded1990
- HeadquartersWebster, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Ansh Labs firmographics
Firmographics- Name
- Ansh Labs
- Legal name
- Ansh Labs
- Website
- https://anshlabs.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Ansh Labs industry classification
Industry- Product category
- Immunoassay Kits and Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
- akta.pro secondary industries
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)
Keywords
Where Ansh Labs is headquartered
LocationHeadquarters
- HQ city
- Webster
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ansh Labs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology/R&D, Operations, Supply Chain, Marketing/Sales
Revenue model
- Immunoassay Product Sales: Sale of ELISA kits, CLIA kits, and immunoassay reagents for research use only (RUO), in vitro diagnostic (IVD), and CE marked applications. Products include highly specific assays with 24-month shelf lives.
- Antibody and Antigen Sales: Sale of monoclonal antibodies and recombinant antigens for research applications. Includes purified antibodies, hybridoma products, and recombinant proteins.
- Custom Immunoassay Development Services: Custom assay development services including ELISA kits, custom biochemical reagents (antibodies, protein and small molecule antigens, specialized conjugates), assay optimization and validation for clinical diagnostics.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | ELISA Kits - Research Use Only (RUO) |
| One time/ perpetual license | Pay-as-you-go | Monoclonal Antibodies |
| One time/ perpetual license | Pay-as-you-go | MenoCheck picoAMH ELISA (FDA Cleared) |
| One time/ perpetual license | Pay-as-you-go | C-Peptide of Insulin ELISA |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Ansh Labs product offering
Product offeringCore offering
Ansh Labs develops and manufactures immunodiagnostic assays and reagents, including ELISA and CLIA kits, monoclonal antibodies, recombinant antigens, and custom biochemical reagents for translational research and clinical diagnostics. The company also offers custom immunoassay development services and provides FDA-cleared, CE-marked, and Research Use Only (RUO) versions of its products to research and clinical laboratories, pharmaceutical/biotech firms, and veterinary diagnostic customers worldwide.
Product overview
Ansh Labs is an immunoassay development company specializing in novel clinical diagnostic markers with applications in reproductive medicine, neurodegenerative disorders, oncology, and metabolism. The product portfolio consists of immunoassay kits (ELISA and CLIA formats), monoclonal antibodies, antigens, and biochemical reagents. Key products include the FDA-cleared MenoCheck picoAMH ELISA for menopausal status determination, various reproductive hormone assays (Inhibin, Activin, FSH, LH, AMH), glucagon regulation assays (GLP-1, GLP-2, Glucagon, Glicentin, Oxyntomodulin), growth factor assays (IGF, IGFBP, GDF, PAPP-A), and species-specific assays for veterinary research (bovine, equine, canine, porcine, ovine). The company offers custom immunoassay development services for unique assay needs.
Differentiator
Problem solved
Functional benefit
Brands
- MenoCheck: FDA cleared in vitro diagnostic test for determining menopausal status in women between 42 and 62 years of age.
Products and services
- MenoCheck picoAMH ELISA
Quantifiable outcome
- 24-month shelf life for immunoassay products
- +1 more outcomes
Companies that use Ansh Labs
Customer profileSegments3 records
Ideal customer profiles3 records
Ansh Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Ansh Labs partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights6 records
Ansh Labs competitors and assessment
Company assessmentBroad incumbents
- Roche Diagnostics: Roche Diagnostics is a global diagnostics leader offering FDA-cleared immunoassays for reproductive hormones (e.g., AMH/Elecsys) and metabolic markers on automated platforms; Ansh Labs competes with Roche's specialty biomarker menu, particularly where labs prefer RUO/ELISA flexibility over high-throughput automated analyzers.
- Bio-Techne (R&D Systems): Bio-Techne, through its R&D Systems brand, is a much larger life-science tools incumbent offering thousands of ELISA kits, antibodies, and reagents across reproductive, metabolic, and immunology biomarkers; Ansh Labs competes in overlapping analyte categories but from a much smaller and more specialized base.
- Abcam: Abcam (now part of Danaher) is a broad incumbent supplying antibodies and ELISA kits across reproductive hormones, growth factors, and metabolic biomarkers; its catalog and distribution scale overlap with Ansh Labs' specialty reproductive and TGF-beta superfamily offerings.
- Beckman Coulter: Beckman Coulter provides automated chemiluminescent immunoassays for fertility hormones and metabolic analytes, competing with Ansh Labs' specialty CLIA kits (e.g., FSH CLIA) but at much larger scale and via installed instrument bases.
Direct peers
- Calbiotech / Eagle Biosciences: Eagle Biosciences (distributing Calbiotech assays) is a specialty immunoassay distributor and developer offering ELISA kits for reproductive hormones, growth factors, and metabolic biomarkers, directly competing with Ansh Labs for translational and clinical lab accounts.
- DRG International: DRG International is named alongside Ansh Labs as a co-holder of over 50% market share in the Fertility ELISA Test Kit Market, selling immunoassays (ELISA and CLIA) for reproductive endocrinology and other specialty biomarkers with a comparable global distributor network.
- Sure Bio-Tech: Sure Bio-Tech is the fourth named participant in the Fertility ELISA Test Kit Market alongside Ansh Labs, DRG International, and Monobind, offering immunoassays for reproductive hormones and related biomarkers in a directly overlapping product category.
- ALPCO Diagnostics: ALPCO Diagnostics is a US-based specialty immunoassay developer focused on ELISA kits for metabolic, reproductive, and gastrointestinal biomarkers, closely overlapping Ansh Labs' catalog (e.g., GLP-1, glucagon, AMH, IGF-1) and serving the same translational research and clinical lab customer base.
- Kamiya Biomedical: Kamiya Biomedical is a US-based specialty immunoassay manufacturer offering ELISA kits for reproductive, metabolic, and oncology biomarkers with RUO and clinical positioning closely paralleling Ansh Labs' product portfolio and customer segments.
- Monobind: Monobind is identified in industry market-share data as one of four players (with Ansh Labs) controlling the majority of the Fertility ELISA Test Kit Market, and manufactures ELISA and CLIA kits for hormones, fertility, and metabolic biomarkers with similar RUO/IVD positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Ansh Labs social profiles
Digital presenceAnsh Labs compliance and trust
Trust signalCompliance3 records
Ansh Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ansh Labs leadership team
Management profileNumber of profiles
Profiles3 records
Ansh Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ansh Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ansh Labs
What does Ansh Labs do?
Ansh Labs develops and manufactures immunodiagnostic assays and reagents, including ELISA and CLIA kits, monoclonal antibodies, recombinant antigens, and custom biochemical reagents for translational research and clinical diagnostics. The company also offers custom immunoassay development services and provides FDA-cleared, CE-marked, and Research Use Only (RUO) versions of its products to research and clinical laboratories, pharmaceutical/biotech firms, and veterinary diagnostic customers worldwide.
Is Ansh Labs a public or private company?
Ansh Labs is a private company. It is classified as corporate owned and is currently operating.
When was Ansh Labs founded?
Ansh Labs was founded in 1990. It employs 11 to 50 people.
Where is Ansh Labs based?
Ansh Labs is headquartered in Webster, United States, in the North America region.
How does Ansh Labs make money?
Three revenue lines are on record. Immunoassay Product Sales are the primary driver. The others are antibody and Antigen Sales and custom Immunoassay Development Services.
Who are Ansh Labs's main competitors?
Broad incumbents on record are Roche Diagnostics, Bio-Techne (R&D Systems), Abcam and Beckman Coulter. Direct peers are Calbiotech / Eagle Biosciences, DRG International, Sure Bio-Tech, ALPCO Diagnostics, Kamiya Biomedical and Monobind.
Does Ansh Labs have an API?
No public API is recorded for Ansh Labs.
What industry is Ansh Labs in?
Ansh Labs's product category is Immunoassay Kits and Reagents. Its primary akta.pro industry code is HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.